30 June 2020 projects
Catalent Biologics’ manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222.
3 June 2020 projects
AstraZeneca’s manufacturing facility in North Ryde, Sydney, Australia is involved in the production and export of medicines, and has been operational for more than 60 years.
29 May 2020 Comment
Acute respiratory distress syndrome (ARDS) in Covid-19 patients can lead to death, owing to alveolar damage from lung inflammation, and as such, prevention of ARDS in Covid-19 patients could help...
27 April 2020 Comment
While many drugs have not seen success in treating Covid-19 patients, testing of Roche’s Actemra (tocilizumab) raises hopes that targeting interleukin 6 (IL-6) can effectively treat severe Covid-19 patients experiencing...
23 April 2020 Comment
With the continuing global devastation caused by the Covid-19 pandemic, researchers worldwide are reviewing all available data to identify key trends that could play a role in combating Covid-19. The...
16 April 2020
Here are the potential human coronavirus vaccines/drugs pharmaceutical companies across the world are developing following the Wuhan coronavirus outbreak (COVID-19).
14 April 2020 Comment
In early January, when the coronavirus outbreak was being watched as a developing global threat, AbbVie was one of the first companies to donate its HIV protease inhibitors combination therapy...
2 April 2020 News
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create a 3D model of Covid-19’s spike protein.